Enrocat Flavour 25 mg/ml Oral Suspension for Cats

None.

Special precautions for safe use in the target species:
Official and local antimicrobial policies should be taken into account when the
veterinary medicinal product is used.
Fluoroquinolones should be reserved for the treatment of clinical conditions which
have responded poorly, or are expected to respond poorly, to other classes of
antimicrobials.
Whenever possible, fluoroquinolones should only be used based on susceptibility
testing.
Use of the veterinary medicinal product deviating from the instructions given in the
SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and
may decrease the effectiveness of treatment with other quinolones due to the
potential for cross resistance.
If there is no clinical improvement observed within 2-3 days of therapy, re-evaluation
of treatment and susceptibility testing may be necessary.
Enrofloxacin is eliminated renally. As with all fluoroquinolones, delayed excretion can
therefore be expected in the presence of existing renal damage.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Direct contact with the skin should be avoided due to sensitisation, contact dermatitis
and possible hypersensitivity reactions.
People with known hypersensitivity to (fluoro)quinolones should avoid contact with
the veterinary medicinal product.
Wash hands after use.
In the event of accidental splash into the eye, rinse with large amounts of clean
water. If irritation occurs, seek medical advice.
Do not eat, drink or smoke while handling the veterinary medicinal product.
Take care to avoid accidental self-injection.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or label to the physician.
Special precautions for the protection of the environment:
Not applicable.